Feb 12, 2018 1:00:00 AM

GenomeWeb – Proteomics International Investing in CPR Pharma Services

NEW YORK (GenomeWeb) – Proteomics International said today it has entered a strategic alliance with CPR Pharma Services focused on clinical trials and related research.

Article: Proteomics International Investing in CPR Pharma Services

2018

MedTech pioneer Proteomics International (PILL; ASX: PIQ) has entered into a strategic alliance...

Proteomics International has contracted French immunoassay specialist Biotem to manufacture test...

PERTH, W. AUSTRALIA, Feb 12, 2018 – (ACN Newswire) – MedTech pioneer Proteomics International...

GenomeWeb – Proteomics International Investing in CPR Pharma Services

Related posts

Bloomberg – Proteomics International Alliance and Investment in CPR Pharma

Proteomics International contracts Biotem to manufacture PromarkerD test kits

ACN Newswire – Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services Targeting New Diagnostic Tests and Improved Drug Development